Mandate

Vinge advises Chieftain Capital Management in connection with the investment in Koenigsegg Automotive

Vinge has advised Chieftain Capital Management, Inc. (”Chieftain”), a New York based family office, in its investment in the Swedish megacar manufacturer Koenigsegg Automotive AB (“Koenigsegg”).

The investment, which coincided with Koenigseggs 30th anniversary, was executed through a share issue. The investment will be used to support the next growth chapter for Koenigsegg and further strengthens the company's position as a global leader in the megacar industry.

Majority owner Christian von Koenigsegg, through his family holding company, is also increasing his stake in the company alongside Chieftain.

Vinge’s team consisted of Magnus Pauli, Petronella Hallberg, Jenny Sandlund, Amelia Rihs, Adam Loewenstein, Michael Montner, Fredrik Löwenclou, Hanna Jansson and Anna Högsten.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026